Specifications TableSubject*Biochemistry, Nanomedicine*Specific subject area*Cancer Research*Type of dataTables\
GraphsHow data were acquiredCell culture (DMEM and RPMI 1640 used as growth media), Inverted microscope (Olympus), microplate reader (Infinite M1000, Tecan)Data formatRaw\
AnalyzedParameters for data collectionCells were maintained in appropriate growth media in an incubator at 37 °C, 5% CO~2~; and 95% humidity. HeLa Cells were grown in DMEM while PC3 and PNT1A were grown in RPMI 1640. Cells passaged 1--2 times a week. Cells were harvested and assayed at 60--75% confluence.Description of data collectionThe cytotoxicity was determined by measuring the absorbance signal of resazurin dye on the treated cell lines at 570nm and 600nm in a microplate reader.Data source locationInstitution: United States Army Medical Research Directorate - Kenya (USAMRD-K), Department of Emerging Infectious Diseases (DEID), Influenza Laboratory\
City: Nairobi\
Country: KenyaData accessibilityWith the article

**Value of the Data**•The data shows potential anticancer activity of AgNPs on HeLa, PC3 and PNT1A cells and highlights differences in cytotoxic activity of the treatments on the cell lines.•The data can be used by academics, students, researchers and industrialists poised in the cancer drugs development.•The data can be used to elucidate the 50% inhibitory concentration (IC~50~) values of the treatments on the cancer cell lines.•The data can be used to investigate the selectivity of the treatments by elucidating the selectivity indices, and thus inform researchers about the safety of such treatments.•The data can be highlighted for further studies in development of better anticancer drugs using green synthesized nanoparticles.

1. Data {#sec1}
=======

The raw data of the treatments against the HeLa, PC3 and PNT1A cells are shown in the different Tables described in this section. Each experiment (Exp.) was represented by four independent replicates (Rep.). [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"} show the data for cytotoxicity of silver nanoparticles derived from fruits extracts of *Annona muricata* (AgNPs-F) on HeLa, PC3 and PNT1A cells; [Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"} show the data for cytotoxicity of silver nanoparticles derived from leaves extracts of *Annona muricata* (AgNPs-L) on HeLa, PC3 and PNT1A cells; while [Table 7](#tbl7){ref-type="table"}, [Table 8](#tbl8){ref-type="table"}, [Table 9](#tbl9){ref-type="table"} show the data for cytotoxicity of 5FU on HeLa, PC3 and PNT1A cells. On the other hand, [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"} show the growth inhibition curves for cells treated with AgNPs-F, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"} show growth inhibition curves of cells treated with AgNPs-L, while [Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"}, [Fig. 9](#fig9){ref-type="fig"} show the growth inhibition curves for cells treated with 5FU.Table 1Data for cytotoxicity of the AgNPs-F against HeLa Cells using the Resazurin metabolic assay.Table 1Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 11.46981.31351.22951.26671.39321.4757Rep. 21.42910.90981.29941.28861.36881.4914Rep. 31.54941.36171.22751.31841.38021.4947Rep. 41.38660.88551.31761.29261.38831.5741Mean Absorbance of Reps.1.458731.117631.26851.291581.382631.50897A600Rep. 10.7751.14891.05591.08490.88450.646Rep. 20.81970.81861.10041.08540.90190.8163Rep. 30.65541.16911.06881.11440.81150.6728Rep. 40.75780.79871.11321.09880.91220.636Mean Absorbance of Reps.0.751970.983831.084571.095870.877530.69277Net Absorbance (A570-A600)0.706760.13380.183930.195710.50510.8162% Cell Viability10018.931526.024427.691171.4670115Exp. 2A570Rep. 11.54271.21090.97671.31231.3231.444Rep. 21.56530.9271.13171.11781.33431.5014Rep. 31.46611.29441.22871.41691.35511.4673Rep. 41.44130.98681.11811.06731.43211.4468Mean Absorbance of Reps.1.503851.104771.11381.228571.361131.46488A600Rep. 10.55421.05570.83841.11670.78090.6737Rep. 20.48770.80980.9610.94820.84980.5827Rep. 30.45311.07481.00261.15510.83750.6709Rep. 40.43480.86310.92130.89830.77120.7523Mean Absorbance of Reps.0.482450.950850.930821.029580.809850.6699Net Absorbance (A570-A600)1.02140.153920.182980.198990.551250.79498% Cell Viability10015.069517.914619.482153.972977.8324Exp. 3A570Rep. 11.4461.3131.25621.26061.43061.4939Rep. 21.49971.18841.31071.42391.43661.5769Rep. 31.39131.15041.28251.5341.47561.5519Rep. 41.34991.20111.30061.27131.4411.6484Mean Absorbance of Reps.1.421721.213231.28751.372451.445951.56777A600Rep. 10.5031.0911.05431.0610.61980.4778Rep. 20.39380.97621.05161.14930.70630.5043Rep. 30.37510.92971.02991.21240.66760.4227Rep. 40.40320.97831.04031.0270.7780.5372Mean Absorbance of Reps.0.418770.99381.044021.112420.692920.4855Net Absorbance (A570-A600)1.002950.219430.243480.260030.753031.08227% Cell Viability10021.878824.276325.926575.0815108% Mean Cell Viability ± SD100 ± 018.6266 ± 3.4022.7384 ± 4.2724.3666 ± 4.3266.8405 ± 11.29100.2775 ± 19.75Table 2Data for cytotoxicity of the AgNPs-F against PC3 Cells using the Resazurin metabolic assay.Table 2Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 11.33331.15851.04721.18851.27511.2804Rep. 21.24561.28921.11791.17091.25781.5277Rep. 31.21131.30571.09651.28151.30691.6487Rep. 41.15471.310.91381.11961.27751.6191Mean Absorbance of Reps.1.236231.265851.043851.190131.279331.51897A600Rep. 10.87431.04641.01630.90570.98130.9847Rep. 20.79741.18540.83470.88930.96261.234Rep. 30.81591.24550.82020.97550.99991.3307Rep. 40.77621.26241.0030.85640.98371.3069Mean Absorbance of Reps.0.815951.184920.918550.906730.981871.21408Net Absorbance (A570-A600)0.420280.080920.12530.28340.297450.3049% Cell Viability10019.255229.813867.43270.775172.5477Exp. 2A570Rep. 11.15291.42771.04161.16981.28761.6169Rep. 21.3021.16721.14241.18841.3441.7367Rep. 31.22331.23821.84031.17541.24911.4129Rep. 41.14721.18361.06471.28951.341.4508Mean Absorbance of Reps.1.206351.254171.272251.205781.305181.55432A600Rep. 10.65681.74620.74790.90040.98521.2206Rep. 20.86261.03410.81020.93221.04241.2958Rep. 30.81621.20451.74650.95570.96521.0876Rep. 40.81451.01091.05931.01681.02881.1233Mean Absorbance of Reps.0.787521.248931.090970.951281.00541.18182Net Absorbance (A570-A600)0.418830.005250.181280.25450.299780.3725% Cell Viability1001.253543.281860.765271.575288.9393Exp. 3A570Rep. 11.14651.18261.27761.31871.41391.3651Rep. 21.12371.29391.28061.05121.3741.6522Rep. 31.30811.25681.26491.4011.33591.2984Rep. 41.0531.2281.1111.20291.40661.7333Mean Absorbance of Reps.1.157821.240331.233521.243451.38261.51225A600Rep. 10.541.05710.95711.10271.13061.0439Rep. 20.67661.26220.96341.01641.07161.3143Rep. 30.9281.15681.06481.12811.03121.0449Rep. 40.71521.11271.02980.99071.09831.3841Mean Absorbance of Reps.0.714951.14721.003781.059481.082921.1968Net Absorbance (A570-A600)0.442870.093130.229750.183980.299670.31545% Cell Viability10021.027451.876941.541167.665871.2278% Mean Cell Viability ± SD100 ± 013.8454 ± 10.9441.6575\
±11.1256.5795 ± 13.4470.0054 ± 2.0777.5716 ± 9.87Table 3Data for cytotoxicity of the AgNPs-F against PNT1A normal cells using the Resazurin metabolic assay.Table 3Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 11.06621.3221.17461.31050.96541.0308Rep. 21.02521.26221.14721.18191.12661.146Rep. 31.07351.51411.11291.09661.22352.0434Rep. 41.06791.47031.09641.20521.22611.1985Mean Absorbance of Reps.1.05821.392151.132781.198551.13541.35468A600Rep. 10.43550.98980.70020.63340.7750.669Rep. 20.55350.96170.77560.7330.96490.5Rep. 30.5071.16260.77180.69981.10271.3381Rep. 40.58951.11430.91090.86111.03040.8164Mean Absorbance of Reps.0.521381.05710.789630.731830.968250.83087Net Absorbance (A570-A600)0.536820.335050.343150.466730.167150.5238% Cell Viability10062.413363.922186.941731.136897.5737Exp. 2A570Rep. 11.04031.04611.1081.11461.00121.053Rep. 21.09481.27271.09251.1051.1781.1035Rep. 31.02391.15151.08471.13411.28481.1462Rep. 41.05951.34751.03361.06171.28991.0691Mean Absorbance of Reps.1.054631.204451.07971.103851.188471.09295A600Rep. 10.64390.80890.62010.60130.79370.483Rep. 20.4560.96120.82540.76890.98550.5061Rep. 30.62730.89990.66210.82891.13050.6187Rep. 40.48681.00540.78010.85181.06030.8104Mean Absorbance of Reps.0.55350.918850.721930.762720.99250.60455Net Absorbance (A570-A600)0.501130.28560.357770.341120.195980.4884% Cell Viability10056.991871.394468.071839.10797.4607Exp. 3A570Rep. 11.40671.43491.17621.22421.70421.2268Rep. 21.34371.34231.21151.24361.68921.3645Rep. 31.18851.37441.15321.22791.57481.3597Rep. 41.30561.32651.15471.30411.75451.3102Mean Absorbance of Reps.1.311131.369531.17391.249951.680681.3153A600Rep. 10.80951.1280.85240.85040.71390.9781Rep. 20.59711.05110.71170.73220.63830.7012Rep. 30.55681.06990.83820.92590.70670.6284Rep. 40.65091.04170.75840.91220.68070.7825Mean Absorbance of Reps.0.653581.072680.790180.855170.68490.77255Net Absorbance (A570-A600)0.657550.296850.383730.394780.995780.54275% Cell Viability10045.144958.356860.0373151.43782.5412% Mean Cell Viability ± SD100 ± 054.85\
±8.8364.5578 ± 6.5471.6836 ± 13.8173.8936 ± 67.2792.5252 ± 8.65Table 4Data for cytotoxicity of the AgNPs-L against HeLa Cells using the Resazurin metabolic assay.Table 4Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 10.93000.85481.03640.97330.96540.9224Rep. 21.36461.01821.27640.96541.12661.1541Rep. 31.20941.39141.33381.29951.22351.1968Rep. 41.30591.17961.28991.19521.22611.2324Mean Absorbance of Reps.1.202471.1111.234121.108351.13541.12642A600Rep. 10.61420.83950.84560.74110.7750.5721Rep. 20.92940.97511.03880.69710.96490.6962Rep. 31.00031.43231.09191.11551.10270.9274Rep. 40.86111.18571.07250.92071.03040.9128Mean Absorbance of Reps.0.851251.108151.01220.86860.968250.77713Net Absorbance (A570-A600)0.351220.002850.221920.239750.167150.3493% Cell Viability1000.8114463.18668.261147.590699.4519Exp. 2A570Rep. 10.95510.88541.04291.00871.00120.9341Rep. 21.40891.06531.29391.0061.1781.1937Rep. 31.24441.45371.3621.35431.28481.2442Rep. 41.32921.23821.31491.24991.28991.264Mean Absorbance of Reps.1.23441.160651.253431.154731.188471.159A600Rep. 10.61790.85330.87230.76010.79370.5722Rep. 20.95040.99481.08550.71290.98550.712Rep. 31.01681.46491.15221.13981.13050.9507Rep. 40.87051.21561.13150.9451.06030.9185Mean Absorbance of Reps.0.86391.132151.060380.889450.99250.78835Net Absorbance (A570-A600)0.37050.02850.193050.265280.195980.37065% Cell Viability1007.692352.105371.599252.8947100.04Exp. 3A570Rep. 11.6181.44861.41341.44381.70421.5772Rep. 21.61321.37991.35231.36661.68921.5764Rep. 31.58711.38931.34971.31771.57481.4538Rep. 42.26741.35001.35081.50111.75451.4657Mean Absorbance of Reps.1.771431.391951.366551.40731.680681.51828A600Rep. 10.79611.04791.28821.12220.71390.7698Rep. 20.84121.06621.18981.09080.63830.8527Rep. 30.81300.99421.17781.12270.70670.8380Rep. 41.01220.92901.17590.98300.68070.9100Mean Absorbance of Reps.0.865631.009321.207931.079680.68490.84263Net Absorbance (A570-A600)0.90580.382630.158630.327620.995780.67565% Cell Viability10042.241717.512136.1697109.93374.5915% Mean Cell Viability ± SD100 ± 016.9151 ± 22.244.2678 ± 23.8258.6767 ± 19.5670.1395 ± 34.5691.3613 ± 14.53Table 5Data for cytotoxicity of the AgNPs-L against PC3 Cells using the Resazurin metabolic assay.Table 5Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 11.06561.00330.85481.04721.18851.2751Rep. 21.05040.85981.01821.11791.17091.2578Rep. 30.98361.13821.39141.09651.28151.3069Rep. 40.99480.97121.17960.91381.11961.2775Mean Absorbance of Reps.1.02360.993121.1111.043851.190131.27933A600Rep. 10.60451.08540.83951.01630.90570.9813Rep. 20.61520.84810.97510.83470.88930.9626Rep. 30.64721.14271.43230.82020.97550.9999Rep. 40.62181.01941.18571.0030.85640.9837Mean Absorbance of Reps.0.622171.02391.108150.918550.906730.98187Net Absorbance (A570-A600)0.40143−0.03070.002850.12530.28340.29745% Cell Viability100−7.66640.7099731.213870.598574.0985Exp. 2A570Rep. 10.95780.93340.88541.04161.16981.2876Rep. 21.15711.07541.06531.14241.18841.344Rep. 31.11371.08461.45371.84031.17541.2491Rep. 41.06170.96291.23821.06471.28951.34Mean Absorbance of Reps.1.072571.014071.160651.272251.205781.30518A600Rep. 10.53020.92950.85330.74790.90040.9852Rep. 20.82970.85060.99480.81020.93221.0424Rep. 30.7641.13261.46491.74650.95570.9652Rep. 40.830.93811.21561.05931.01681.0288Mean Absorbance of Reps.0.738470.96271.132151.090970.951281.0054Net Absorbance (A570-A600)0.33410.051380.02850.181280.25450.29978% Cell Viability10015.37718.5303754.257776.174889.7261Exp. 3A570Rep. 11.3231.1321.44861.27761.31871.4139Rep. 21.29661.21851.37991.28061.05121.374Rep. 31.28711.19951.38931.26491.4011.3359Rep. 41.2091.18041.351.1111.20291.4066Mean Absorbance of Reps.1.278921.18261.391951.233521.243451.3826A600Rep. 11.02411.08881.04790.95711.10271.1306Rep. 20.93431.08711.06620.96341.01641.0716Rep. 30.94661.11220.99421.06481.12811.0312Rep. 41.08841.21770.9291.02980.99071.0983Mean Absorbance of Reps.0.998351.126451.009321.003781.059481.08292Net Absorbance (A570-A600)0.280570.056150.382630.229750.183980.29967% Cell Viability10020.0125136.37281.885465.5707106.807% Mean Cell Viability ± SD100 ± 09.24106 ± 7.1648.5374 ± 76.1655.7856 ± 25.3770.7813 ± 5.390.2107 ± 16.36Table 6Data for cytotoxicity of the AgNPs-L against PNT1A normal cells using the Resazurin metabolic assay.Table 6Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 11.24071.08661.24061.31371.26930.9282Rep. 21.12320.89721.281.28041.28560.9183Rep. 31.2691.53881.18281.25671.0690.9439Rep. 41.26011.27971.20091.3031.2350.8617Mean Absorbance of Reps.1.223251.200571.226071.288451.214720.91302A600Rep. 10.77430.7460.96531.05370.99540.4771Rep. 20.66540.97761.04651.01911.01131.0198Rep. 30.71170.950.96851.00860.84960.7099Rep. 40.94481.03520.94741.04970.99551.0908Mean Absorbance of Reps.0.774050.92720.981921.032770.962950.8244Net Absorbance (A570-A600)0.44920.273380.244150.255680.251770.08862% Cell Viability10060.858254.352256.917956.049619.7295Exp. 2A570Rep. 11.15151.16191.12571.19351.15480.9842Rep. 21.2111.30641.20021.19321.15261.3729Rep. 31.08921.3821.40511.29781.24151.2624Rep. 41.26571.16991.16821.37041.29961.2985Mean Absorbance of Reps.1.179351.255051.22481.263721.212131.2295A600Rep. 10.58640.99680.87340.94590.90920.4771Rep. 20.71930.94330.99860.93830.89341.0198Rep. 30.711.21821.10521.01810.97640.7099Rep. 40.81151.22380.94161.09791.00631.0908Mean Absorbance of Reps.0.70681.095520.97971.000050.946330.8244Net Absorbance (A570-A600)0.472550.159520.24510.263670.26580.4051% Cell Viability10033.758351.867555.798356.24885.7264Exp. 3A570Rep. 11.12751.0351.25631.39471.29131.1149Rep. 21.28021.1561.19971.40591.32511.246Rep. 31.21551.19911.25311.09141.38461.2462Rep. 41.26741.21781.29821.46321.33681.2599Mean Absorbance of Reps.1.222651.151981.251831.33881.334451.21675A600Rep. 10.82740.7460.99991.12871.04710.9102Rep. 20.68110.97760.9791.15631.06740.623Rep. 30.67370.951.03780.89261.09790.9252Rep. 40.76681.03521.03291.19171.07380.9023Mean Absorbance of Reps.0.737250.92721.01241.092321.071550.84018Net Absorbance (A570-A600)0.48540.224780.239430.246480.26290.37657% Cell Viability10046.307249.325350.777754.161577.5803% Mean Cell Viability ± SDs100 ± 046.9746 ± 13.5651.8483 ± 2.5154.498 ± 3.2355.4864 ± 1.1561.0121 ± 35.98Table 7Data for cytotoxicity of 5FU against HeLa Cells using the Resazurin metabolic assay.Table 7Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 10.93000.99171.21990.80061.01931.0169Rep. 21.36461.1861.26381.17291.11811.207Rep. 31.20941.02871.18941.17521.06461.1992Rep. 41.30591.1711.15631.08091.13071.1797Mean Absorbance of Reps.1.202471.094351.207351.05741.083181.1507A600Rep. 10.61420.86241.1270.6990.92530.8917Rep. 20.92941.10431.19011.06421.0741.1148Rep. 31.00031.00221.13491.16091.02591.0741Rep. 40.86111.1441.1021.07541.04921.1133Mean Absorbance of Reps.0.851251.028231.13850.999881.01861.04847Net Absorbance (A570-A600)0.351220.066120.068850.057520.064570.10223% Cell Viability10018.82719.602816.378418.385629.1053Exp. 2A570Rep. 10.95511.0171.23670.83721.05071.0592Rep. 21.40891.21171.31151.21111.15621.2348Rep. 31.24441.09831.27191.23541.121.2559Rep. 41.32921.22251.2131.13331.16851.2467Mean Absorbance of Reps.1.23441.137371.258281.104251.123851.19915A600Rep. 10.61790.88651.15110.72140.94860.9195Rep. 20.95041.12681.21731.08681.09541.1367Rep. 31.01681.03831.17351.20211.05731.1011Rep. 40.87051.17491.13331.10271.07121.1387Mean Absorbance of Reps.0.86391.056631.16881.028251.043121.074Net Absorbance (A570-A600)0.37050.080750.089480.0760.080720.12515% Cell Viability10021.794924.149820.512821.788133.7787Exp. 3A570Rep. 11.6181.38691.41091.44611.58861.51Rep. 21.61321.27181.41721.50961.46241.5024Rep. 31.58711.3061.42151.51381.3741.4649Rep. 42.26741.20121.3931.36691.38331.4478Mean Absorbance of Reps.1.771431.291471.410651.45911.452071.48128A600Rep. 10.79610.99320.94621.09640.72750.9649Rep. 20.84120.82921.07721.00130.90730.8436Rep. 30.8130.97331.00020.86111.04230.9563Rep. 41.01220.99241.11140.97390.95660.9414Mean Absorbance of Reps.0.865630.947031.033750.983180.908430.92655Net Absorbance (A570-A600)0.90580.344450.37690.475920.543650.55473% Cell Viability10038.027241.609652.54260.018861.2414Mean % Cell Viability ± SD100 ± 026.2163 ± 10.3328.4541 ± 11.6229.811 ± 19.7933.3975 ± 23.1141.3751 ± 17.36Table 8Data for cytotoxicity of 5FU against PC3 Cells using the Resazurin metabolic assay.Table 8Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 11.33331.22951.45981.35091.50991.3809Rep. 21.24561.25651.31261.21951.35861.259Rep. 31.21131.25281.41941.25091.4541.277Rep. 41.15471.2191.38561.27661.36221.2752Mean Absorbance of Reps.1.236231.239451.394351.274481.421181.29802A600Rep. 10.87431.12431.35351.09841.30061.1187Rep. 20.79741.0581.19411.09041.11270.9825Rep. 30.81591.1010.9690.99381.21251.0203Rep. 40.77621.05781.09781.08031.12131.0756Mean Absorbance of Reps.0.815951.085271.15361.065721.186771.04928Net Absorbance (A570-A600)0.420280.154180.240750.208750.23440.24875% Cell Viability10036.684357.283949.669955.77359.1874Exp. 2A570Rep. 11.15291.12561.09221.1891.10881.2155Rep. 21.3021.07362.06651.18931.26981.1701Rep. 31.22331.04791.25371.17691.29811.1123Rep. 41.14721.06591.05551.12811.16681.1998Mean Absorbance of Reps.1.206351.078251.366981.170831.210881.17443A600Rep. 10.65680.80580.65210.87020.78140.8249Rep. 20.86260.87342.08760.87020.89660.8882Rep. 30.81620.77550.98041.02620.97850.7266Rep. 40.81450.93180.99410.80940.85771.0238Mean Absorbance of Reps.0.787520.846631.178550.8940.878550.86587Net Absorbance (A570-A600)0.418830.231620.188430.276820.332320.30855% Cell Viability10055.303544.98966.095679.34773.6704Exp. 3A570Rep. 11.14651.05290.98791.40991.03421.215Rep. 21.12371.18871.2511.21781.2741.2613Rep. 31.30811.32311.22961.21991.39731.3347Rep. 41.0531.29151.33691.31051.32491.3175Mean Absorbance of Reps.1.157821.214051.201351.289531.25761.28212A600Rep. 10.540.71760.71931.1950.79240.9112Rep. 20.67660.86331.10520.82491.03031.0017Rep. 30.9281.22480.94051.10321.12821.0617Rep. 40.71521.0191.01621.05461.07631.039Mean Absorbance of Reps.0.714950.956180.94531.044421.00681.0034Net Absorbance (A570-A600)0.442870.257870.256050.24510.25080.27872% Cell Viability10058.227557.815455.342956.6362.9354Mean % Cell Viability ± SD100 ± 050.0718 ± 11.6953.3628 ± 7.2657.0361 ± 8.3463.9167 ± 13.3765.2644 ± 7.52Table 9Data for cytotoxicity of 5FU against PNT1A normal cells using the Resazurin metabolic assay.Table 9Concentration (μg/ml)Wavelength/nmReplicatesBlank200100502512.5Exp. 1A570Rep. 11.06620.92821.04141.0851.03121.0644Rep. 21.02520.91831.11521.07591.04721.1821Rep. 31.07350.94391.27421.10651.18351.2094Rep. 41.06790.86170.91681.16911.04811.1196Mean Absorbance of Reps.1.05820.913021.08691.109131.07751.14388A600Rep. 10.43550.47710.470.4820.50630.5058Rep. 20.55351.01980.6750.69880.63710.6727Rep. 30.5070.70990.85790.60310.8520.7457Rep. 40.58951.09080.57060.79680.69330.7201Mean Absorbance of Reps.0.521380.82440.643380.645180.672170.66107Net Absorbance (A570-A600)0.536820.088620.443520.463950.405330.4828% Cell Viability10016.509182.6286.424875.504189.9362Exp. 2A570Rep. 11.04030.98420.99561.08391.06141.0555Rep. 21.09481.37291.06571.0880.99430.9717Rep. 31.02391.26240.98411.08461.08021.1183Rep. 41.05951.29851.07441.08321.071.1113Mean Absorbance of Reps.1.054631.22951.029951.084921.051481.0642A600Rep. 10.64390.47710.59450.48930.48230.4356Rep. 20.4561.01980.54940.66730.69060.5797Rep. 30.62730.70990.7010.68970.6330.5618Rep. 40.48681.09080.63930.68750.63220.6472Mean Absorbance of Reps.0.55350.82440.621050.633450.609530.55607Net Absorbance (A570-A600)0.501130.40510.40890.451470.441950.50812% Cell Viability10080.838181.596490.092388.1916101.397Exp. 3A570Rep. 11.40671.11491.27541.28141.25131.3242Rep. 21.34371.2461.12331.21891.22081.216Rep. 31.18851.24621.11051.18161.29431.1357Rep. 41.30561.25991.15011.00691.22661.1305Mean Absorbance of Reps.1.311131.216751.164821.17221.248251.2016A600Rep. 10.80950.91020.87071.04490.95410.7732Rep. 20.59710.6230.68060.71040.66010.741Rep. 30.55680.92520.74610.7080.63880.5442Rep. 40.65090.90230.70080.67250.67960.66Mean Absorbance of Reps.0.653580.840180.749550.783950.733150.6796Net Absorbance (A570-A600)0.657550.376570.415270.388250.51510.522% Cell Viability10057.269463.154959.044978.336279.3856% Mean Cell Viability ± SD100 ± 051.5389 ± 32.5575.7904 ± 10.9578.5207 ± 16.9780.6773 ± 6.6690.2396 ± 11.0Fig. 1A graph showing the Cytotoxicity of AgNPs-F against HeLa Cells using the Resazurin Metabolic Assay.Fig. 1Fig. 2A graph showing the Cytotoxicity of AgNPs-F against PC3 Cells using the Resazurin Metabolic Assay.Fig. 2Fig. 3A graph showing the Cytotoxicity of AgNPs-F against PNT1A Cells using the Resazurin Metabolic Assay.Fig. 3Fig. 4A graph showing the Cytotoxicity of AgNPs-L against HeLa Cells using the Resazurin Metabolic Assay.Fig. 4Fig. 5A graph showing the Cytotoxicity of AgNPs-L against PC3 Cells using the Resazurin Metabolic Assay.Fig. 5Fig. 6A graph showing the Cytotoxicity of AgNPs-L against PNT1A Cells using the Resazurin Metabolic Assay.Fig. 6Fig. 7A graph showing the Cytotoxicity of 5FU against HeLa Cells using the Resazurin Assay.Fig. 7Fig. 8A graph showing the Cytotoxicity of 5FU against PC3 Cells using the Resazurin Metabolic Assay.Fig. 8Fig. 9A graph showing the Cytotoxicity of 5FU against PNT1A Cells using the Resazurin Metabolic Assay.Fig. 9

1.1. Data for cytotoxicity of AgNPs-F on HeLa, PC3 and PNT1A cells {#sec1.1}
------------------------------------------------------------------
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1.2. Data for cytotoxicity of AgNPs-L on HeLa, PC3 and PNT1A cells {#sec1.2}
------------------------------------------------------------------

.

1.3. Data for cytotoxicity of 5FU on HeLa, PC3 and PNT1A cells {#sec1.3}
--------------------------------------------------------------

.

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Chemicals and reagents {#sec2.1}
---------------------------

All chemicals and reagents were procured from certified suppliers and were of the highest analytical standard. DMEM, RPMI1640, Penicillin/Streptomycin, Non-Essential Amino Acids, Trypsin-EDTA, and Resazurin were obtained from Solarbio (China). FCS, 5FU, Phosphate buffered saline (PBS) and Dimethyl Sulfoxide (DMSO) were obtained from Sigma Aldrich (Germany).

2.2. The silver nanoparticles {#sec2.2}
-----------------------------

Previously prepared and characterized AgNPs from ethanolic extracts of fruits and leaves of *Annona muricata* were used for the study from which the current data was obtained [@bib1], [@bib2]. AgNPs-F used had an absorption maximum at 427 nm and were stable under different pH, Temperature and storage conditions. The AgNPs-F had an average crystalline size of 60.12 nm, a polydispersity index of 0.1235 and were spherical in nature. The functional groups responsible for the formation of the AgNPs included; Alkanes and alkyls, aldehydes and esters, nitro groups, alcohol groups, amines, amides, alkenes, acids and alkyl halides [@bib1], [@bib2]. On the other hand, AgNPs-L used had an absorption maximum at 429 nm and were stable under different pH, Temperature and storage conditions. The AgNPs-L had an average crystalline size of 87.36 nm, a polydispersity index of 0.16 and were spherical in nature. The functional groups responsible for the formation of the AgNPs included; Alkanes and alkyls, aldehydes and esters, nitro groups, alcohol groups, amines, amides, alkenes, acids and alkyl halides [@bib1].

2.3. Cell lines {#sec2.3}
---------------

The HeLa and PC-3 cells were Cervical and Prostate adenocarcinomas respectively. On the other hand, the PNT1A cells were normal immortalized prostate cells. HeLa, PC3, and PNT1A were sourced from the European collection of Animal Cell Cultures (ECACC). All cells were adherent.

2.4. Cell culture {#sec2.4}
-----------------

The cells were grown separately in appropriate media (HeLa in DMEM; PC3 and PNT1A in RPMI 1640) containing [l]{.smallcaps}-Glutamine and supplemented with 10% batch tested inactivated fetal calf serum (FCS), 1% Penicillin/Streptomycin, and 1% Non-essential amino acids. The cells were kept an incubator at 37 °C, 5% CO~2~; and 95% humidity. Cells were Trypsinized and passaged 1--2 times a week and were harvested and used for the assays during their logarithmic growth phase at about 60--75% confluence.

2.5. Preparation of the AgNPs solutions, 5-FU and blanks in media {#sec2.5}
-----------------------------------------------------------------

AgNPs-F and AgNPs-L stock solutions (10mg/ml) were prepared by dispersing them in 0.5% DMSO in culture media. Briefly, 100mg of the AgNPs were dispersed in 10 mL of culture medium (containing Dimethyl Sulfoxide (DMSO) of 0.5%v/v). Required treatment concentrations of (200, 100, 50, 25, and 12.5 μg/mL were then made by dilutions of the stock solutions using the formula C~1~V~1~000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000C~2~V~2~. To prepare the standard anticancer treatment regimen of 5-FU, a stock solution was prepared as above and then diluted with culture media to desired concentrations ranging from 12.5 to 200 μg/mL. The final concentration of dimethyl sulfoxide (DMSO) in each cell culture did not exceed 1% v/v to keep the cytotoxicity of DMSO low [@bib3].

2.6. Measurement of the anticancer activities of the AgNPs and 5FU using the Resazurin Assay {#sec2.6}
--------------------------------------------------------------------------------------------

The effects of the AgNPs on each of the cell lines\' viability and death was determined using the Resazurin (7-hydroxy-10-oxido- phenoxazin-10-ium-3-one) assay as previously described [@bib4], [@bib5], [@bib6], [@bib7]. Exponentially growing cells were harvested, washed and seeded in 96 well plates containing 0.5 × 10^4^Cells/well and incubated with 100 μL per well culture media and allowed to attach overnight. Seeding media was then removed from each of the plates. The attached cultured cells were then treated by adding of 100 μL of the treatments at concentrations of 200, 100, 50, 25, and 12.5μg/mL (in culture media). In addition, the DMSO alone in media was added to another set of cells as the solvent control blank (DMSO = 0.5%v/v). Standard drug 5-FU was used as a reference drug for cancer as positive control. The treated cells were then incubated in a humified CO~2~ incubator at 37 °C. 24 Hours from the start of the incubation, 20 μl resazurin at a concentration of 0.15mg/ml in PBS was added to each of the wells and then incubated at 37 °C for an additional 4 hours. After 4 hours from the addition of resazurin, the plates containing the treated cells were then retrieved from the incubator and the absorbance signal was quickly measured at 570/600nm (excitation/emission wavelengths), using a microplate reader (Infinite M1000, Tecan). Each treatment was read in at least four replicates.

2.7. How the data can be analyzed {#sec2.7}
---------------------------------

The presented data can be analyzed by determining the percentage cell viability using the formula: % Viability = (Net absorbance of treated samples/Net absorbance of blank) ×100. The effect of the samples on the proliferation of the cell lines can then be expressed in form of graphs of percentage cell viability against logarithm of concentration as shown in [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"}, [Fig. 9](#fig9){ref-type="fig"} under the data section above. Fifty percent of inhibitory concentration (IC~50~) or cytotoxic concentration (CC~50~) of each of the treatments can then be calculated from the growth inhibition curves.
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